Cetera Trust Company’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,195
Closed -$238K 355
2025
Q2
$238K Buy
12,195
+1,225
+11% +$21.8K 0.14% 148
2025
Q1
$195K Hold
10,970
0.12% 163
2024
Q4
$235K Sell
10,970
-900
-8% -$21.9K 0.15% 145
2024
Q3
$371K Hold
11,870
0.23% 80
2024
Q2
$184K Hold
11,870
0.12% 169
2024
Q1
$126K Hold
11,870
0.08% 194
2023
Q4
$142K Buy
+11,870
New +$97.2K 0.09% 180

Other funds holding CDNA

Cetera Trust Company's CDNA Position: Q3 2025 in Review

Cetera Trust Company sold out of CareDx (CDNA) in Q3 2025, closing a stake of 12,195 shares — an estimated $238K sold.

Cetera Trust Company first reported a position in CDNA in Q4 2023 and held it in 7 quarters. The position peaked at $371K in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Cetera Trust Company reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Cetera Trust Company sold 12,195 CareDx shares in Q3 2025, an estimated $238K.
  • Cetera Trust Company first reported a position in CareDx in Q4 2023 and held it in 7 quarters.
  • Cetera Trust Company's CareDx position peaked at $371K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Cetera Trust Company's 13F filing for Q3 2025, filed 13 Nov 2025.